Bristol-Myers Squibb (BMY)
Bristol-Myers Squibb Max Pain By Strike
BMY trades at $46.32, pinned near the near-term max pain of $47 expiring Sep 12, 2025 (4 days). Price stability likely with balanced options positioning at this level. Max pain is stable across expirations ($45-$52.5), indicating stable market expectations. Key magnetic zone at 47 where 6 expirations converge.
Bristol-Myers Squibb Max Pain By Expiry
Max pain for BMY shows stable levels around 47.82, reflecting balanced market expectations. The 16% spread signals divergent expectations across timeframes. Most levels above 46.32 could support dips. Strong magnetic level at 47 (6 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 12, 2025 | 47 | 0.68 (1.48%) |
| Sep 19, 2025 | 47 | 0.68 (1.48%) |
| Sep 26, 2025 | 47 | 0.68 (1.48%) |
| Oct 3, 2025 | 47 | 0.68 (1.48%) |
| Oct 10, 2025 | 48 | 1.68 (3.64%) |
| Oct 17, 2025 | 45 | -1.32 (-2.84%) |
| Oct 24, 2025 | 46 | -0.32 (-0.68%) |
| Nov 21, 2025 | 47 | 0.68 (1.48%) |
| Dec 19, 2025 | 49 | 2.68 (5.80%) |
| Jan 16, 2026 | 48 | 1.68 (3.64%) |
| Mar 20, 2026 | 45 | -1.32 (-2.84%) |
| Jun 18, 2026 | 50 | 3.68 (7.96%) |
| Sep 18, 2026 | 45 | -1.32 (-2.84%) |
| Dec 18, 2026 | 47 | 0.68 (1.48%) |
| Jan 15, 2027 | 52.5 | 6.18 (13.35%) |
| Jun 17, 2027 | 52.5 | 6.18 (13.35%) |
| Dec 17, 2027 | 50 | 3.68 (7.96%) |